You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket ⤷  Try a Trial Date Filed 2017-03-05
Court District Court, D. Delaware Date Terminated 2019-03-04
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties TEVA PHARMACEUTICALS USA, INC.
Patents 6,953,787; 7,514,422; 7,977,329; 8,168,624; 8,207,158; 8,273,734; 8,367,657; 8,546,379; 8,575,149; 8,697,686; 8,946,207; 8,980,881; 8,999,970; 9,169,213
Attorneys Karen Elizabeth Keller
Firms Shaw Keller LLP
Link to Docket External link to docket

Details for Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-03-28 12 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,168,624 B2; US 8,367,657 …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2017-03-28 13 21, 2017. Date of Expiration of Patent: April 18, 2029 re: US 8,168,624 B2. (Keller, Karen) (Entered: 03… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2017-03-28 14 21, 2017. Date of Expiration of Patent: April 10, 2023 re: US 8,367,657 B2. (Keller, Karen) (Entered: 03… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2017-03-28 15 , 2017. Date of Expiration of Patent: December 20, 2025 re: US 8,697,686 B2. (Keller, Karen) (Entered:… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2017-03-28 16 21, 2017. Date of Expiration of Patent: June 16, 2024 re: US 8,946,207 B2. (Keller, Karen) (Entered: 03… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2017-03-28 17 , 2017. Date of Expiration of Patent: December 20, 2025 re: US 8,980,881 B2. (Keller, Karen) (Entered:… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
2019-03-05 26 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,953,787 B2; 7,514,422 B2; 7,977,329…2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.